The company seeks to raise additional capital.
The post Medical Developments share price halted amid ‘significant near-term opportunities’ appeared first on The Motley Fool Australia. –
The Medical Developments International Ltd (ASX: MVP) share price is on ice today following a company requested trading halt.
The ASX granted the trading pause before market open. Prior to being put into the trading halt, the last bid for the Medical Developments share price was $2.40 apiece.
What was announced?
Medical Developments advised that it will complete a fully underwritten capital raising of $30 million.
This will be comprised of a $15 million placement and a $15 million pro rata accelerated non-renounceable entitlement offer.
It hopes to achieve a cash balance of $49 million post offer to fund three core areas. Per the announcement:
Post transaction MVPâs cash balance will be A$49m which will fund:
– continuing execution of the Companyâs direct sales strategy in the large European
market
– expansion of the Australian business into the emergency sector and further growth in
the ambulance sector
– further investment in business capability to enable global growth
The 1 for 9.5 pro-rata accelerated non-renounceable entitlement offer seeks to raise $15 million. It comes with 1 attaching option to acquire 1 fully paid ordinary share for every 2.5 new shares
issued.
Whereas the placement is targeted towards sophisticated investors with 1 option for every 2.5 new shares issued.
Speaking on the announcement, chairman Gordon Naylor said the company was “pleased with [its] strong revenue growth in FY22and expect this to continue into FY23”.
“With a strong funding position following the capital raising, we look forward to investing to continue to deliver on our growth strategy.”
The Medical Developments share price is down more than 42% this year to date.
The post Medical Developments share price halted amid ‘significant near-term opportunities’ appeared first on The Motley Fool Australia.
Should you invest $1,000 in Medical Developments International Ltd right now?
Before you consider Medical Developments International Ltd, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medical Developments International Ltd wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
See The 5 Stocks
*Returns as of July 7 2022
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
Zooming higher: The Zip share price is up 7%
Why is the Kogan share price kicking goals on Thursday?
Why is the Mesoblast share price on ice today?
Why Apple stock popped today
Why are ASX 200 tech shares having such a stellar run today?
Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
